CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

NCT07181720 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
90
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chongqing Precision Biotech Co., Ltd